logo 600X600.png
Neuroscience Market to Surpass US$ 43.32 Billion by 2030, Says Coherent Market Insights (CMI)
19 mai 2023 09h31 HE | CMI
Burlingame, May 19, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global neuroscience market is estimated to be valued at US$ 32.75 billion in 2023 and is expected to exhibit a...
emotiv-logo-ol (2).png
EMOTIV Enlists Two Machine Learning Heavyweights as AI Takes Aim at the Human Brain
01 mai 2023 09h00 HE | Emotiv Inc.
SAN FRANCISCO, May 01, 2023 (GLOBE NEWSWIRE) -- EMOTIV, the bioinformatics pioneer advancing understanding of the human brain using electroencephalography (EEG), today added two renowned scientists...
NeurologyLive.png
NeurologyLive® and CMSC Announce Giants of Multiple Sclerosis® 2023 Class of Inductees
26 avr. 2023 09h19 HE | NeurologyLive
CRANBURY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) are pleased to announce the 2023 Giants of Multiple Sclerosis® inductees. ...
NOVARTIS logo.jpg
Novartis presents new five-year data on disability outcomes and safety of Kesimpta® (ofatumumab) in people living with relapsing multiple sclerosis
20 avr. 2023 01h15 HE | Novartis Pharma AG
The ALITHIOS open-label extension study showed continuous treatment with Kesimpta® (ofatumumab) for up to five years in relapsing multiple sclerosis (RMS) patients was associated with reduced risk of...
GMILogo_Vertical-Gradient.png
Magnetoencephalography Market to hit USD 534 Million by 2032, says Global Market Insights Inc.
18 avr. 2023 05h22 HE | Global Market Insights Inc.
Selbyville, Delaware, April 18, 2023 (GLOBE NEWSWIRE) -- Magnetoencephalography market value is estimated to exceed USD 534 million by 2032, according to a new research report by Global Market...
Biogen_Logo_Standard-rgb_R.jpg
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS
22 mars 2023 20h31 HE | Biogen Inc.
CAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System...
Webinar Presenter
Neuroscience of Stress and Metabolism - A Free Webinar from the Brain & Behavior Research Foundation
07 mars 2023 10h15 HE | Brain & Behavior Research Foundation
New York, March 07, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Neuroscience of Stress and Metabolism” on Tuesday, March 14, 2023, at...
The Dan Lewis Foundation for Brain Regeneration Research Announces First Annual DLF Prize to Be Awarded Spring 2023 DENVER, Feb. 23, 2023 (GLOBE NEWSWIRE) -- The Dan Lewis Foundation for Brain Regeneration Research (the DLF) happily announces the 2023 DLF Prize. This $15,000 prize will be awarded to an early...
Webinar Presenter
Therapeutic Targeting of the Microbiome for Neurodevelopmental Disorders - A Free Webinar from the Brain & Behavior Research Foundation
08 févr. 2023 13h23 HE | Brain & Behavior Research Foundation
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Therapeutic Targeting of the Microbiome for Neurodevelopmental Disorders”...
Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor
25 janv. 2023 04h00 HE | AKAMPION
- Claus Andersson, PhD, joins Rewind´s Board of Directors Leuven, Belgium, January 25, 2023 --- Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated...